U.S. Markets open in 4 hrs 51 mins

Biogen Expected to Report Robust Rise in Diluted EPS in 2018

Margaret Patrick
Biogen Expected to Report Robust Rise in Diluted EPS in 2018

In its Q2 2018 earnings conference call, Biogen (BIIB) updated its 2018 GAAP EPS guidance from the previously projected range of $22.20–$23.20 to $21.80–$22.40, which implies a YoY (year-over-year) rise of 83%–87%.